L-tetrahydropalamatine: A potential new medication for the treatment of cocaine addiction

Future Medicinal Chemistry

Volumn 4, Issue 2, 2012, Pages 177-186

  Wang, Jia Bei ^a   Mantsch, John R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

An intense; overwhelming and often uncontrollable desire to use a drug

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DRUGS USED IN THE TREATMENT OF ADDICTION; HERBACEOUS AGENT; LEVO TETRAHYDROPALMATINE; UNCLASSIFIED DRUG;

CHINA; COCAINE DEPENDENCE; DRUG EFFICACY; DRUG METABOLISM; DRUG STRUCTURE; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BERBERINE ALKALOIDS; COCAINE-RELATED DISORDERS; DRUGS, CHINESE HERBAL; HUMANS;

EID: 84863011788     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.11.166     Document Type: Review

References (61)

1. Office of National Drug Control Policy (2004). The Economic Costs of Drug Abuse in the United States, 1992-2002. Washington, DC: Executive Office of the President (Publication No. 207303).
2. Yanhusuo. Pharmacopoeia of the People's Republic of China I: 108-108 (2000).
3. Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell. Mol. Neurobiol. 28, 491-499 (2008). (Pubitemid 351637559)
4. Xu SX, Jin GZ, Yu LP, Liu GX, Lu WW, Fang SD. Brain dopamine depleted by d-tetrahydropalmatine. Acta Pharm. Sinica 8, 207-212 (1987).
5. Liu GQ, Algeri S, Garattini S. d-l-tetrahydropalmatine as monoamine depletor. Arch. Int. Pharm. Therap. 258, 39-50 (1982).
6. Rotundine. Pharmacopoeia of the People's Republic of China II: 338-339 (2010).
7. Li L, Ye M, Bi K, Guo D. Liquid chromatography-tandem mass spectrometry for the identification of l-tetrahydropalmatine metabolites in Penicillium janthinellum and rats. Biomed. Chromatogr. 20, 95-100 (2006). (Pubitemid 43141411)
8. Lai CK, Chan AY. Tetrahydropalmatine poisoning: diagnoses of nine adult overdoses based on toxicology screens by HPLC with diode-array detection and gas chromatography-mass spectrometry. Clin. Chem. 45, 229-236 (1999). (Pubitemid 29079121)
9. Ma ZZ, Xu W, Jensen NH, Roth BL, Liu-Chen LY, Lee DY. Isoquinoline alkaloids isolated from Corydalis Yanhusuo and their binding affinities at the dopamine D1 receptor. Molecules 13, 2303-2312 (2008).
10. Jin GZ. Progress in studies of the pharmacology of l-tetrahydropalmatine and l-stepholidine. Acta Pharm. Sinica 22, 472-480 (1987).
11. Jin GZ, Xu J, Zhang FT, Yu LP, Li JH, Wang XL. Relevance of the sedative-tranquilizing effect of l-tetrahydropalmatine to brain monoaminergic neurotransmitters. Acta Pharm. Sinica 4, 4-10 (1983). (Pubitemid 13045107)
12. Huang K, Dai GZ, Li XH, Fan Q, Cheng L, Feng YB, Xia GJ, Yao WX. Blocking L-calcium current by l-tetrahydropalmatine in single ventricular myocyte of guinea pigs. Acta Pharm. Sinica 20, 907-911 (1999).
13. Mantsch JR, Li SJ, Risinger R, Awad S, Katz E, Baker DA, Yang Z. Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacology 192, 581-591 (2007). (Pubitemid 46870752)
14. Hong Z, Fan G, Le J, Chai Y, Yin X, Wu Y. Brain pharmacokinetics and tissue distribution of tetrahydropalmatine enantiomers in rats after oral administration of the racemate. Biopharm. Drug Dispos. 27, 111-117 (2006).
15. Xi ZX, Gilbert J, Campos AC, Kline N, Ashby CR Jr, Hagan JJ, Heidbreder CA, Gardner EL. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 176, 57-65 (2004). (Pubitemid 39506367)
16. Marcenac F, Jin GZ, Gonon F. Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum. Psychopharmacology 89, 89-93 (1986). (Pubitemid 16062969)
17. Jin GZ, Wang XL, Shi WX. Tetrahydroprotoberberine: a new chemical type of antagonist of dopamine receptors. Sci. Sinica Series B Chem. Biol. Agricult. Med. Earth Sci. 29, 527-534 (1986).
18. Lu ZZ, Wei X, Jin GZ, Han QD. Antagonistic effect of tetrahydroproberberine homologues on a 1-adrenoceptor. Acta Pharm. Sinica 31, 652-656 (1996). (Pubitemid 126436283)
19. Halbsguth C, Meissner O, Haberlein H. Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABA(A) binding site. Plant. Med. 69, 305-309 (2003). (Pubitemid 36577994)
20. Anderson SM, Pierce RC. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharm. Therap. 106, 389-403 (2005). (Pubitemid 40731541)
21. Self DW. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47(Suppl. 1), 242-255 (2004). (Pubitemid 39298268)
22. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 47(Suppl. 1), 3-13 (2004). (Pubitemid 39298248)
23. Kuhar MJ, Ritz MC, Boja JW. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299-302 (1991).
24. Platt DM, Rowlett JK, Spealman RD. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163, 265-282 (2002).
25. Xi ZX, Yang Z, Li SJ et al. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Neuropharmacology 53, 771-782 (2007). (Pubitemid 47532146)
26. Mantsch JR, Wisniewski S, Vranjkovic O et al. Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats. Pharm. Biochem. Behav. 97, 310-316 (2010).
27. Childress AR, O'Brien CP. Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharm. Sci. 21, 6-9 (2000). (Pubitemid 30102182)
28. Pulvirenti L, Koob GF. Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharm. Sci. 15, 374-379 (1994). (Pubitemid 24325709)
29. Heidbreder CA, Gardner EL, Xi ZX et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. 49, 77-105 (2005). (Pubitemid 40800164)
30. Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs 64, 1547-1573 (2004). (Pubitemid 38981839)
31. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am. J. Psychiatry 162, 1432-1440 (2005). (Pubitemid 41105557)
32. Jin GZ, Zhu ZT, Fu Y. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharm. Sci. 23, 4-7 (2002). (Pubitemid 34135965)
33. Fleckenstein AE, Gibb JW, Hanson GR. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacology 406, 1-13 (2000).
34. Filip M, Alenina N, Bader M, Przegalinski E. Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addiction Biol. 15, 227-249 (2010).
35. Weinshenker D, Schroeder JP. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32, 1433-1451 (2007). (Pubitemid 46920149)
36. Zhang XY, Kosten TA. Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol. Psychiatry 57(10), 1202-1204 (2005). (Pubitemid 40615783)
37. Burmeister JJ, Lungren EM, Kirschner KF, Neisewander JL. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29, 660-668 (2004). (Pubitemid 38402473)
38. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. a-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23, 138-150 (2000). (Pubitemid 30406898)
39. Imaki J, Mae Y, Shimizu S, Ohno Y. Therapeutic potential of a2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders. Neurosci. Lett. 454, 143-147 (2009).
40. Wadenberg ML. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. 20, 325-339 (1996).
41. Kalkman HO, Neumann V, Hoyer D, Tricklebank MD. The role of a2- adrenoceptor antagonism in the anticataleptic properties of the atypical neuroleptic agent, clozapine, in the rat. Br. J. Pharmacology 124, 1550-1556 (1998). (Pubitemid 28360580)
42. Hu JY, Jin GZ. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Acta Pharm. Sinica 20, 715-719 (1999).
43. Figueroa-Guzman Y, Mueller C, Vranjkovic O et al. Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats. Drug Alcohol Depend. 116, 72-79 (2011).
44. Mello NK, Negus SS. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14, 375-424 (1996). (Pubitemid 26271172)
45. Haney M, Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology 199, 403-419 (2008).
46. Zhao Y, Hellum BH, Liang A, Nilsen OG. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine. Phytotherapy Res. doi:10.1002/ptr.3554 (2011) (Epub ahead of print).
47. Stafford D, LeSage MG, Glowa JR. Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139, 169-184 (1998). (Pubitemid 28439514)
48. Richardson NR RD. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66, 1-11 (1996).
49. Kornetsky C, Bain G. Brain-stimulation reward: a model for the study of the rewarding effects of abused drugs. NIDA 124, 73-93 (1992). (Pubitemid 23081975)
50. Spealman RD. Use of cocaine-discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. NIDA 119, 175-179 (1992).
51. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168, 3-20 (2003). (Pubitemid 36851158)
52. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol. Rev. 54, 1-42 (2002). (Pubitemid 34208828)
53. Li C-W, Zhang S, Gao H-Q, Zhang X-M. Determination of l-tetrahydropalmatine in human plasma by HPLC and pharmacokinetics of its disintegrating tablets in healthy Chinese. Eur. J. Drug Metab. Pharm. 36(4), 257-262 (2011).
54. Zhang J, Tan L, Zhou J, Lu X, Yuan Y. Determination of rotundine in human plasma by HPLC and pharmacokinetic studies. J. China Pharm. Univ. 29, 67-70 (1998).
55. Wu G, Jiang JW, Wu GC, Cao XD. Effects of four dopamine agonists on l- tetrahydropalmatine-induced analgesia and electroacupuncture analgesia in rabbits. Acta Pharm. Sinica 11, 196-200 (1990). (Pubitemid 20246768)
56. Yang Z, Shao YC, Li SJ et al. Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharm. Sinica 29, 781-788 (2008).
57. Hu Y, Qiu Y, Zhong Y, He H. Therapeutic effects of rotundine combined with methadone in treatment of heroin dependence. Chin. J. Drug Abuse Prev. Treat. 12, 270-271 (2006).
58. Horowitz RS, Feldhaus K, Dart RC, Stermitz FR, Beck JJ. The clinical spectrum of Jin Bu Huan toxicity. Arch. Int. Med. 156, 899-903 (1996). (Pubitemid 26120595)
59. Woolf GM, Petrovic LM, Rojter SE et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann. Int. Med. 121, 729-735 (1994).
60. Picciotto A, Campo N, Brizzolara R et al. Chronic hepatitis induced by Jin Bu Huan. J. Hepatology 28, 165-167 (1998). (Pubitemid 28122515)
61. Liu YL, Yan LD, Zhou PL, Wu CF, Gong ZH. Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats. Eur. J. Pharmacology 602, 321-327 (2009).